[Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].
La hidroxicloroquina como fármaco fundamental en dermatología y su papel controvertido en la COVID-19.
COVID-19
Dermatology
Hydroxychloroquine
Lichen planus
Lupus erythematosus
Supply shortages
Journal
Actas dermo-sifiliograficas
ISSN: 1578-2190
Titre abrégé: Actas Dermosifiliogr
Pays: Spain
ID NLM: 0373062
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
18
04
2021
accepted:
15
07
2021
pubmed:
10
8
2021
medline:
10
8
2021
entrez:
9
8
2021
Statut:
ppublish
Résumé
Hydroxychloroquine is an antimalarial drug with immunomodulatory, anti-inflammatory, antibacterial, and antiviral properties. It has a good safety profile, can be used in children and in pregnant and breastfeeding women, and does not suppress the immune system. Regular screening for retinopathy, one of the drug's most feared adverse effects, is necessary. Hydroxychloroquine is a widely used, essential drug in dermatology. Clinical response rates are good in lupus erythematous, where it is a first-line therapy, as well in numerous autoimmune/inflammatory diseases, including lichen planus, polymorphic light eruption, porphyria cutanea tarda, granuloma annulare, and sarcoidosis. In 2020, it was widely prescribed both to prevent and to treat COVID-19 caused by SARS-CoV-2. Its increased use led to serious supply shortages and in some cases stocks were entirely depleted. Recent meta-analyses have concluded that hydroxychloroquine is ineffective against COVID-19 and have advised against its use.
Identifiants
pubmed: 34366433
doi: 10.1016/j.ad.2021.07.005
pii: S0001-7310(21)00297-0
pmc: PMC8326180
pii:
doi:
Types de publication
English Abstract
Journal Article
Langues
spa
Pagination
166-175Informations de copyright
© 2021 AEDV. Published by Elsevier España, S.L.U.
Références
Semin Arthritis Rheum. 1988 May;17(4):221-31
pubmed: 3232080
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1402-9
pubmed: 22985607
PLoS One. 2022 Aug 29;17(8):e0273389
pubmed: 36037216
JAMA Ophthalmol. 2014 Dec;132(12):1453-60
pubmed: 25275721
J Am Acad Dermatol. 2010 Mar;62(3):387-92
pubmed: 20061052
Br J Dermatol. 1996 Feb;134(2):373
pubmed: 8746362
Br J Dermatol. 1987 Mar;116(3):379-86
pubmed: 3552020
J Am Acad Dermatol. 1993 Apr;28(4):609-12
pubmed: 8463463
Arthritis Care Res (Hoboken). 2018 Mar;70(3):481-485
pubmed: 28556555
J Am Acad Dermatol. 2019 Jun;80(6):1658-1663
pubmed: 30703458
Australas J Dermatol. 2012 Feb;53(1):e10-3
pubmed: 22309344
Pediatr Dermatol. 2018 May;35(3):361-365
pubmed: 29575039
Indian J Med Microbiol. 2021 Apr;39(2):159-170
pubmed: 33781656
J Invest Dermatol. 2021 Aug;141(8):1906-1914.e2
pubmed: 33675790
Ann Rheum Dis. 2021 Feb;80(2):1-2
pubmed: 32586918
J Am Acad Dermatol. 2021 Oct;85(4):1046-1047
pubmed: 33607179
Cutis. 2008 Apr;81(4):351-4
pubmed: 18491485
J Rheumatol. 2020 Jun 1;47(6):787-790
pubmed: 32269064
J Am Acad Dermatol. 2021 Feb;84(2):543-545
pubmed: 32439466
J Am Acad Dermatol. 1990 Sep;23(3 Pt 1):487-9
pubmed: 2212149
Dermatology. 2016;232(1):86-90
pubmed: 26445088
Photodermatol. 1984 Dec;1(6):286-92
pubmed: 6398430
Arch Dermatol. 2008 Jan;144(1):118-9
pubmed: 18209184
J Am Acad Dermatol. 2017 Jun;76(6):1176-1182
pubmed: 28318681
Dev World Bioeth. 2021 Dec;21(4):193-200
pubmed: 32844516
Dermatol Ther. 2021 May;34(3):e14903
pubmed: 33605044
J Am Acad Dermatol. 2019 Aug;81(2):568-580
pubmed: 30953702
J Dermatol. 2019 Apr;46(4):285-289
pubmed: 30719729
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188
pubmed: 32323646
Int J Womens Dermatol. 2017 Jun 13;3(4):189-194
pubmed: 29234712
Australas J Dermatol. 2020 May;61(2):e150-e157
pubmed: 31612996
J Am Acad Dermatol. 2017 Apr;76(4):765-767
pubmed: 28325398
J Allergy Clin Immunol. 2019 Feb;143(2):458-466
pubmed: 30268388
Dermatology. 2005;211(2):167-8
pubmed: 16088169
Dermatol Ther. 2020 Jul;33(4):e13524
pubmed: 32383251
Arthritis Rheumatol. 2015 Feb;67(2):527-34
pubmed: 25385679
Dermatol Ther. 2017 May;30(3):
pubmed: 28168851
Indian Dermatol Online J. 2020 May 10;11(3):453-464
pubmed: 32695719
J Am Acad Dermatol. 2020 Mar;82(3):709-722
pubmed: 31306730
Cochrane Database Syst Rev. 2021 Feb 12;2:CD013587
pubmed: 33624299
Eur Ann Allergy Clin Immunol. 2017 Sep;49(5):220-224
pubmed: 28884989
Br J Dermatol. 2010 Dec;163(6):1296-300
pubmed: 20698851
Int J Dermatol. 2010 Apr;49(4):467-9
pubmed: 20465710
Actas Dermosifiliogr (Engl Ed). 2021 Feb;112(2):118-126
pubmed: 33045209
Cutis. 2017 Nov;100(5):312-316
pubmed: 29232421
N Engl J Med. 2021 Feb 4;384(5):417-427
pubmed: 33289973
Br J Dermatol. 2021 Jul;185(1):201-203
pubmed: 33548058
Dermatol Ther. 2020 Sep;33(5):e13829
pubmed: 32542964
Indian J Dermatol Venereol Leprol. 2008 Jan-Feb;74(1):18-22
pubmed: 18187817
J Am Acad Dermatol. 2014 Apr;70(4):670-678
pubmed: 24508293
Int J Prev Med. 2017 May 25;8:37
pubmed: 28584619
J Am Acad Dermatol. 1994 Mar;30(3):510
pubmed: 8113476
Australas J Dermatol. 2019 May;60(2):e109-e112
pubmed: 30411331
JAMA Dermatol. 2019 Apr 1;155(4):494-496
pubmed: 30673076